Bioventus

BVS · NASDAQ

$13.95+$0.46 (+3.41%)TodayMarket closed ·
Prev close $13.49

Who owns BVS

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 63.1% of BVS’s shares.

  • EW Healthcare Partners19.2%
  • Juniper Investment Company, LLC10.2%
  • Smith & Nephew Group plc9.2%
  • Nantahala Capital Management, LLC8.9%
  • Next 6 largest institutions15.6%
  • All other shareholders36.9%
Top institutional holders of BVS
HolderShares% of shares
EW Healthcare Partners13.02M19.22%
Juniper Investment Company, LLC6.94M10.24%
Smith & Nephew Group plc6.23M9.20%
Nantahala Capital Management, LLC6.00M8.86%
BlackRock Institutional Trust Company, N.A.3.13M4.63%
Royce Investment Partners1.83M2.71%
Vanguard Capital Management, LLC1.75M2.59%
Geode Capital Management, L.L.C.1.37M2.02%
American Century Investment Management, Inc.1.35M2.00%
Dimensional Fund Advisors, L.P.1.13M1.67%

Largest mutual fund holders

Top mutual fund holders of BVS
HolderShares% of shares
Avantis US Small Cap Value ETF1.52M2.25%
iShares Russell 2000 ETF1.25M1.84%
Vanguard Total Stock Market Index Fund1.16M1.72%
FTGF Royce US Small Cap Opportunity Fund874.90K1.29%
Royce Small-Cap Opportunity Fund858.74K1.27%

Insider trades

Form 4 filings by officers, directors and large holders

Insiders made no open-market buys or sales of BVS in the last 6 months.

Latest BVS insider transactions
InsiderTypeSharesValue
McMurry-Heath MichelleAward25.15K—
Ladone Mary KayAward25.15K—
Cowdy Philip G.Award25.15K—
Beyer PatAward25.15K—
Bartholdson John A.Award25.15K—
NEELS GUIDO JAward25.15K—
STALNECKER SUSAN MAward25.15K—
NOHRA GUY PAward25.15K—
HAWKINS WILLIAM AAward30.99K—
SUTTER MARTIN PAward25.15K—

Short interest

Settled Sep 30, 2026

Shares short
3.16M
Days to cover
6.70
% of shares outstanding
4.67%
Average daily volume
471.64K
Change since last report
+7.9%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.